Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials

Optimal prostate SABR dose-fractionation is unknown. This study compares long-term outcomes from two prospective trials.

https://ift.tt/2pI9rXD